Dosing Variability and Clinical Outcomes of Oxybutynin: A Pediatric Cohort of Patients With Neurogenic Bladder.

Malik, Mahnoor F; Randall, Joseph Hogan; Campbell, Jack G; McLaughlin, Matthew J; Koenig, Joel F

Malik, Mahnoor F; Randall, Joseph Hogan; Campbell, Jack G; McLaughlin, Matthew J; Koenig, Joel F.

Afiliação

Malik MF; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri.
Randall JH; Department of Urology, University of Kansas, Kansas City, Kansas.
Campbell JG; Department of Urology, University of Kansas, Kansas City, Kansas.
McLaughlin MJ; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri.
Koenig JF; Division of Rehabilitation Medicine, Children's Mercy Kansas City, Kansas City, Missouri.

Top Spinal Cord Inj Rehabil ; 28(3): 9-14, 2022.

Article em En | MEDLINE | ID: mdl-36017125

Assuntos

Traumatismos da Medula Espinal; Bexiga Urinaria Neurogênica; Criança; Feminino; Humanos; Masculino; Ácidos Mandélicos/efeitos adversos; Ácidos Mandélicos/uso terapêutico; Estudos Retrospectivos; Bexiga Urinaria Neurogênica/tratamento farmacológico; Urodinâmica

Palavras-chave

cholinergic antagonists; neurogenic; pediatrics; spinal dysraphism; urinary bladder

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Traumatismos da Medula Espinal / Bexiga Urinaria Neurogênica Tipo de estudo: Observational_studies / Prognostic_studies Limite: Child / Female / Humans / Male Idioma: En Revista: Top Spinal Cord Inj Rehabil Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google